Veeva, a leading cloud-based application, offers Luckie an additional avenue for sourcing healthcare content and data while helping our clients keep up with global marketing challenges. Its multichannel customer relationship management (CRM) suite requires multiple levels of software training and certification. Luckie has met all pre-defined criteria and has received certification for the first two levels: Veeva CLM and Veeva Approved Email. With this certification and with a strong background in using data-driven insights to optimize the customer journey, Luckie can deliver sound CRM solutions for our clients who want to partner with Veeva.
Veeva CLM (closed-loop marketing) focuses on tailoring and tracking in-person meetings between our healthcare clients and their customers. With this tool, Luckie can quickly access and assemble approved content modules into sales presentations. Engagement is tracked at the customer level, giving us more data to understand who customers are, to subsequently predict and deliver relevant content across channels, and to strengthen client-customer relationships over time.
Veeva CRM Approved Email extends the sales conversation before, during and after in-person meetings and has the potential to connect hard-to-see healthcare professionals (HCPs). This cloud-based repository of approved email content negates some of the regulatory risks that have restricted personalized communications from field reps in the past and fast-tracks the delivery of valued HCP content directly tied to individual needs and interests. Emails are tracked at the customer level to continue to drive insights.
As a certified Veeva partner, Luckie delivers the benefits of the multichannel suite to help simplify the way for global healthcare clients working with multiple agencies and stakeholders:
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 400 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com.